Advanced Liver Fibrosis Predicts Liver Outcomes in Biopsy-proven Metabolic Dysfunction-associated Steatotic Liver Disease: A U.S.-based Single-center Retrospective Cohort Study
In a U.S. single-center cohort of patients with biopsy-proven MASLD, advanced fibrosis was the primary risk factor for incident liver decompensation and liver-related events.
Authors
- Joseph K. Lim (ORCID: https://orcid.org/0000-0003-1126-8128)
- Dhanpat Jain (ORCID: https://orcid.org/0000-0003-3845-0798)
- Yanhong Deng (ORCID: https://orcid.org/0000-0002-4333-468X)
- Robert Lam (ORCID: https://orcid.org/0000-0002-9658-9299)
- Eesha K. Acharya
Institutions
- University of Michigan (US)
- Yale University (US)
Publication Details
- Journal
- Journal of Clinical and Translational Hepatology
- Published
- 2024-10-17
- DOI
- https://doi.org/10.14218/jcth.2024.00189
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39